Jazz Pharmaceuticals

ISIN IE00B4Q5ZN47

WKN A1JS1K

Marktkapitalisatie (in EUR)

14,160 m

Land

Ireland

Sector

Healthcare

Dividendrendement

0.00%

Overzicht

Koers

Beschrijving

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Toon meer Toon minder

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Ireland

Grafiek

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR	14,160 m
WPA, EUR	12.43
KBV	3.4
K/W	17.6
Dividendrendement	0.00%

Income statement (2025)

Omzet, EUR	3,783 m
Netto-inkomen, EUR	-316 m
Winstmarge	-8.35%

What ETF is Jazz Pharmaceuticals in?

There are 8 ETFs which contain Jazz Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Jazz Pharmaceuticals is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weging	Investeringsfocus	Fondsgrootte (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	1.14%	Equity United States Health Care Biotech	69
Vanguard Russell 1000 U.S. Value UCITS ETF USD Dist	0.04%	Equity United States Value	2
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.02%	Equity World Social/Environmental	553
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.02%	Equity North America Social/Environmental	28
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist	0.11%	Equity United States Mid Cap	3
JPMorgan Global Equity Active UCITS ETF USD (dist)	0.52%	Equity World Social/Environmental	1
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.22%	Equity United States Small Cap	226
Vanguard FTSE Global All-Cap UCITS ETF USD Dist	0.01%	Equity World	9

Prestaties

Rendementsoverzicht

YTD	+46,87%
1 maand	-1,30%
3 maanden	+3,92%
6 maanden	+32,37%
1 jaar	+93,74%
3 jaar	+65,73%
5 jaar	+86,25%
Since inception	+116,38%
2025	+23,85%
2024	+4,51%
2023	-24,44%
2022	+27,06%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).